Atlas Trials

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Clinical trial NCT05840562 · RECRUITING

Trial details

NCT number
NCT05840562
Sponsor
Institut Cancerologie de l'Ouest
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chemotherapy-induced Peripheral Neuropathy
Start date
2023-10-20
Primary completion
2028-03-01
Enrollment
274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.